Revvity | 当期純利益



Net Income 変化する 日付
Adcock Ingram Holdings ZAR 369.84M 74.33M 2024-06
Agilent USD 318M 33M 2025-01
Align Technology USD 103.81M 12.16M 2024-12
Bio Techne USD 34.89M 1.29M 2024-12
Bio-Rad Laboratories USD -715800000 1.37B 2024-12
Bruker USD 13.7M 27.2M 2024-12
Celltrion KRW 85.59B 7.58B 2024-09
Charles River Laboratories USD -215699000 284.38M 2024-12
Cspc Pharmaceutical CNY 757.66M 649.86M 2024-09
Danaher USD 1.09B 268M 2024-12
Dentsply International USD -430000000 64M 2024-12
Dianthus Therapeutics USD -25174000 7.57M 2024-09
Ecofibre AUD 617K 46.2M 2024-06
Edwards Lifesciences USD 385.6M 2.69B 2024-12
Exact Sciences USD -864585000 826.35M 2024-12
Hologic USD 201M 22.4M 2024-12
Illumina USD 187M 518M 2024-12
Intuitive Surgical USD 685.7M 120.6M 2024-12
IQVIA Holdings USD 437M 152M 2024-12
Kangmei Pharma CNY -10744790 19.03M 2024-09
Knight Therapeutics CAD 85K 2.03M 2024-09
Laboratorios Farma EUR 29.38M 14.42M 2024-06
Laboratory Of America USD 143.4M 25.9M 2024-12
Malin Corporation EUR 0 1.1M 2024-06
Medical Developments International AUD -15020000 4.08M 2024-06
Mettler Toledo International USD 252.3M 40.78M 2024-12
Myriad Genetics USD -42500000 20.4M 2024-12
Neuren Pharmaceuticals AUD 134.03M 126.01M 2024-12
Organigram Holdings CAD -22957000 17.52M 2024-12
Patterson Companies USD 31.26M 4.49M 2025-01
Pharma Mar EUR 18.68M 14.78M 2024-12
Qiagen NV USD 88.32M 9.74M 2024-12
Quest Diagnostics USD 222M 4M 2024-12
Quidel USD -178400000 158.5M 2024-12
Repligen USD -653000 3.97M 2024-09
Revvity USD 94.64M 278K 2024-12
Sartorius EUR 14.2M 9.7M 2024-09
Sino Biopharmaceutical CNY 1.51B 435.42M 2024-06
Thermo Fisher Scientific USD 1.83B 201M 2024-12
Tilray USD -85342000 46.18M 2024-11
Waters USD 231.4M 69.9M 2024-12
Zz Pientze Pharmaceu 965.15M 218.11M 2024-09



Revvity 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.